Investor Relations Home

Profile
IRIDEX Corporation was founded in 1989 and is a worldwide leader in developing, manufacturing, and marketing innovative and versatile laser-based medical systems, delivery devices and consumable instrumentation for the ophthalmology market. We maintain a deep commitment to the success of our customers, with comprehensive technical, clinical, and service support programs. IRIDEX is dedicated to a standard of excellence, offering superior technology for superior results. IRIDEX products are sold in the United States through a direct sales force and internationally through a combination of a direct sales force and a network of approximately 70 independent distributors into over 100 countries.
Stock Quote
IRIX (Common Stock)
ExchangeNASDAQ (US Dollar)
Price$8.37
Change (%) Stock is Up 0.01 (0.12%)
Volume39,604
Data as of 08/18/17 4:00 p.m. ET
Minimum 20 minute delay
Refresh quote
Recent NewsMore >>
DateTitle 
08/03/17IRIDEX Announces 2017 Second Quarter, Six-Month Financial Results
Updates Guidance for Full Year 2017 MOUNTAIN VIEW, Calif., Aug. 3, 2017 /PRNewswire/ -- IRIDEX Corporation (Nasdaq: IRIX) today reported financial results for the second quarter and six months ended July 1, 2017. Second Quarter Financial Results and Highlights Total revenue of $10.0 million, a 16% year-over-year decline Sold 69 Cyclo G6 systems and shipped approximately 7,100 G6 probes Participation in the 7th World Glaucoma Congress in Helsinki, including a... 
Printer Friendly Version
07/20/17IRIDEX to Report Second Quarter 2017 Financial Results on August 3, 2017
MOUNTAIN VIEW, Calif., July 20, 2017 /PRNewswire/ -- IRIDEX Corporation (Nasdaq: IRIX) today announced the Company will release financial results for the second quarter 2017 after the close of trading on Thursday, August 3, 2017.  The Company's management team will host a corresponding conference call beginning at 2:00 p.m. PT / 5:00 p.m. ET. Investors interested in listening to the conference call may do so by dialing (844) 707-0665 for domestic callers or (703) 326-3030 for int... 
Printer Friendly Version
07/18/17IRIDEX Announces Appointment Of Ann Rhoads To Its Board Of Directors
MOUNTAIN VIEW, Calif., July 18, 2017 /PRNewswire/ -- IRIDEX Corporation (Nasdaq: IRIX) today announced the appointment of Ann Rhoads to the Company's Board of Directors, Audit Committee, and Compensation Committee, effective immediately. "We are delighted to add Ann to our Board of Directors.  Her significant experience working with growth companies from a financial and strategic perspective, particularly in the healthcare sector, makes her an ideal addition to our leadership... 
Printer Friendly Version
05/24/17IRIDEX To Present At The Jefferies 2017 Global Healthcare Conference
MOUNTAIN VIEW, Calif., May 24, 2017 /PRNewswire/ -- IRIDEX Corporation (Nasdaq: IRIX) today announced the Company plans to participate in the upcoming Jefferies 2017 Global Healthcare Conference in New York, NY. IRIDEX's management is scheduled to present on Wednesday, June 7, 2017 at 4:30pm ET.  Interested parties may access a live and archived webcast of the presentation at www.IRIDEX.com.  About IRIDEX IRIDEX Corporation was founded in 1989 and is a worldwide lead... 
Printer Friendly Version
Primary IR Contact
Lynn Lewis or Leigh Salvo
Phone: (415) 937-5404
E-mail: investors@iridex.com


Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.


logo aa0logo agslogo ascrslogo asrslogo esrs0logo euretina